Related Experiment Video
Updated: Jun 7, 2026

04:23
A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
Published on: April 21, 2023
2.3K
A token efficient vision framework using patch residual transformer for Alzheimer's disease diagnosis.
Fei Huang1, Pengli Zhu2, Nanguang Chen3
1School of Computer Engineering and Science, Shanghai University, Shanghai, China.
Scientific Reports
|January 9, 2026
Summary
A new Patch Residual Transformer (PRT) model improves early Alzheimer's disease (AD) diagnosis and mild cognitive impairment (MCI) conversion prediction using structural MRI. This AI approach enhances focus on critical brain regions, outperforming existing methods.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Neurology
Background:
- Alzheimer's disease (AD) diagnosis relies on structural magnetic resonance imaging (sMRI), but current AI models like Vision Transformers (ViT) face challenges with data redundancy and feature focus.
- Early detection of AD and prediction of mild cognitive impairment (MCI) progression are critical for effective intervention.
Purpose of the Study:
- To introduce a novel, token-efficient framework, the Patch Residual Transformer (PRT), for enhanced sMRI-based AD diagnosis and MCI conversion prediction.
- To address information redundancy and focus loss issues in ViT models applied to high-dimensional neuroimaging data.
Main Methods:
- The PRT model partitions sMRI data into patches and utilizes a Patch Residual Block (PRB) with Top-K patch selection and linear stitch patch token fusion (LSPTF).
- Top-K identifies and ranks critical patches, while LSPTF focuses the model on essential regions, improving efficiency and performance.
- Validation was performed on the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Open Access Series of Imaging Studies-3 (OASIS-3) datasets.
Main Results:
- The PRT model significantly outperformed existing slice-, patch-, ROI-, and subject-level methods for both AD diagnosis and MCI conversion prediction.
- The PRT demonstrated strong generalization capabilities across different datasets.
- Consistent and robust salience maps were generated, highlighting the model's interpretability.
Conclusions:
- The PRT framework offers a superior approach for leveraging sMRI data in AD diagnosis and MCI conversion prediction.
- The proposed PRB, incorporating Top-K and LSPTF, effectively mitigates focus loss and enhances model performance in neuroimaging analysis.
- PRT shows promise for improving early detection and intervention strategies for Alzheimer's disease.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

